These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6523521)

  • 1. Labilising effect of suramin on rat kidney lysosomes in vivo.
    Akanji MA
    Toxicol Lett; 1984 Dec; 23(3):273-7. PubMed ID: 6523521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rat kidney lysosomal membrane damage induced by suramin in vitro and in vivo.
    Akanji MA
    Pharmacol Toxicol; 1988 May; 62(5):318-21. PubMed ID: 3413035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of chloroquine on the stability of rat kidney lysosomes in vivo and in vitro.
    Ngaha EO; Akanji MA
    Comp Biochem Physiol C Comp Pharmacol; 1982; 73(1):109-13. PubMed ID: 6128166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Further studies on the in vivo effect of cephaloridine on the stability of rat kidney lysosomes.
    Ngaha EO
    Biochem Pharmacol; 1982 May; 31(10):1843-7. PubMed ID: 7104015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of cephaloridine on the stability of rat kidney lysosomes.
    Ngaha EO; Fry M; Plummer DT
    Chem Biol Interact; 1979 Feb; 24(2):199-208. PubMed ID: 428010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on gentamicin-induced labilization of rat kidney lysosomes in vitro. Possible protection by selenium.
    Ngaha EO; Ogunleye IO
    Biochem Pharmacol; 1983 Sep; 32(18):2659-64. PubMed ID: 6626237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Decrease in the rats of intraliposomal proteolysis and labilization of rat liver lysosomes following suramin administration].
    Korolenko TA; Pupyshev AB; Malygin AE
    Biull Eksp Biol Med; 1980 Dec; 90(12):686-8. PubMed ID: 6781552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the lysosomotropic drug suramin on islet lysosomal enzyme activities and the insulin-secretory response induced by various secretagogues.
    Panagiotidis G; Salehi AA; Lundquist I
    Pharmacology; 1991; 43(3):163-8. PubMed ID: 1723207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lung macrophage defense responses during suramin-induced lysosomal dysfunction.
    Warr GA; Jakab GJ
    Exp Mol Pathol; 1983 Apr; 38(2):193-207. PubMed ID: 6832343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of lysosomal storage by suramin.
    Buys CH; Bouma JM; Gruber M; Wisse E
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Sep; 304(2):183-90. PubMed ID: 568220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Facilitation of the structural and functional disorders of liver lysosomes in toxic hepatitis due to the suppression of intralysosomal proteolysis].
    Korolenko TA; Pupyshev AB; Malygin AE; Gavrilova NI; Kurysheva NG
    Biull Eksp Biol Med; 1985 Aug; 100(8):169-72. PubMed ID: 3896340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal effects of potassium dichromate in the rat: comparison of urinary enzyme excretion with corresponding tissue patterns.
    Ngaha EO
    Gen Pharmacol; 1981; 12(6):497-500. PubMed ID: 7308739
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of suramin on digestion of 14C-labelled albumin in heterolysosomes of rat liver subcellular fractions].
    Pupyshev AB; Malygin AE; Korolenko TA
    Biokhimiia; 1981 Jul; 46(7):1167-74. PubMed ID: 7272344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effects of testosterone and estradiol on the activity of lysosomal enzymes in rat liver and kidneys].
    Sergeev PV; Dunaev VG; Nichoga VD
    Farmakol Toksikol; 1978; 41(4):445-50. PubMed ID: 97095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Interference of fosfomycin with the integrity of the lysosomal membrane of rat kidney cells].
    Morin JP; Bendirdjian JP; Fillastre JP; Vaillant R
    Minerva Med; 1978 Dec; 69(59):4075-8. PubMed ID: 740302
    [No Abstract]   [Full Text] [Related]  

  • 16. Centrifugal and activation methods for rapid identification of lysosomotropic drugs with the use of rat liver homogenates.
    Jacques PJ; Huybrechts-Godin G; Smeesters C
    Biochem Soc Trans; 1975; 3(1):155-7. PubMed ID: 1126525
    [No Abstract]   [Full Text] [Related]  

  • 17. RAT-KIDNEY LYSOSOMES: ISOLATION AND PROPERTIES.
    SHIBKO S; TAPPEL AL
    Biochem J; 1965 Jun; 95(3):731-41. PubMed ID: 14342509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The suramin-treated rat as a model of mucopolysaccharidosis. Variation in the reversibility of biochemical and morphological changes among different organs.
    Rees S; Constantopoulos G; Brady RO
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1986; 52(3):259-72. PubMed ID: 2879381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterophagic function and rate of intralysosomal proteolysis during lysosomotropic agents administration.
    Korolenko TA; Pupyshev AB; Malygin AE
    Acta Biol Med Ger; 1981; 40(10-11):1613-7. PubMed ID: 7342605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cephaloridine and the rat kidney lysosomes stability in vitro.
    Ngaha EO
    West Afr J Pharmacol Drug Res; 1979; 5(1):25-35. PubMed ID: 555127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.